
Voyage Biomedical
Using cooling to end brain damage during stroke.
About
Acquired by Penumbra (NYSE:PEN).
Topics
- Location
- San Francisco, CA, United States
- Team size
- 3 employees
- YC batch
- Summer 2019
- Status
- Acquired
- Stage
- Early stage

Using cooling to end brain damage during stroke.
Acquired by Penumbra (NYSE:PEN).

What they do:
Portable cryoablation to prevent cervical cancer
Quick facts:
HQ: San Francisco, CA, United States

What they do:
High-precision, closed-loop neuromodulation devices
Quick facts:
HQ: Boston, MA, United States

What they do:
Helping physicians select the right therapy for breast cancer patients
Quick facts:
HQ: Austin, TX, United States

What they do:
Neurostimulation implant to restore hearing & speech understanding
Quick facts:
HQ: San Francisco, CA, United States

What they do:
Robotic Automation for cancer diagnostics - Robotic Microscopes &…
Quick facts:

What they do:
Bringing non-invasive brain stimulation from the hospital to the home
Quick facts:
HQ: Mexico City, Mexico
Using cooling to end brain damage during stroke.
San Francisco, CA, United States
3 employees, according to the company profile.
There are no funding rounds for Voyage Biomedical in our data.
Similar startups: Ananya Health, Torpedo Therapeutics, and NearWave.